MH

MindWalk Holdings Corp.

HYFT·NASDAQ

$1.82

+6.1%
HealthcareBiotechnology

MindWalk Holdings Corp. operates as a bio-native AI company. It focuses on the integration of artificial intelligence, multi-omics data, and advanced laboratory research to accelerate the discovery and development of biologics. The company, through its LensAI platform and HYFT technology, it partners with pharmaceutical and biotechnology companies to drive de-risk drug development and unlock therapeutic possibilities. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company was incorporated in 1983 and is headquartered in Austin, Texas.

At a Glance

Live Snapshot
Market Cap$84.87M
EPS-0.9100
P/E Ratio-2.00
Earnings Date03/26/2026

hyft

Common Stock

Last Annual Value

136.37M

3-Year CAGR

6%

5-Year CAGR

32%

10-Year CAGR

278%

MH

MindWalk Holdings Corp. Competitors Analysis of Common Stock

HYFT · NASDAQ
CompanyCommon Stock
CAGR 3Y
CAGR 5Y
CAGR 10Y
136.37M
5.1%11.2%277.5% 
44.00K
0.8%8.0%N/A
22.00K
-14.3%8.0%N/A
54.00K
2.6%5.7%N/A
1.00K
N/AN/AN/A
98.00K
15.9%28.5%15.1%
CLNN logo
Clene Inc.
NASDAQ:CLNN
1.00K
-57.5%-30.1%N/A
CRVO logo
CervoMed Inc.
NASDAQ:CRVO
8.70K
15.3%33.7%-1.7%
0.00
N/AN/AN/A
XBIT logo
XBiotech Inc.
NASDAQ:XBIT
276.73M
0.7%1.1%1.3%
IMA logo
ImageneBio Inc
NASDAQ:IMA
11.00K
-38.8%-21.1%N/A
MH

MindWalk Holdings Corp. Fair Value Envelope

HYFT · NASDAQ

Our analysis suggests that HYFT has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $1.82, this represents a potential HIDDEN relative to our calculated worth for MindWalk Holdings Corp..

Intrinsic Value
Current Price: $1.82